Company / FCF Margin
CUMBERLAND PHARMACEUTICALS INC FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
41.3%
FY2025
5-year range
8.2% / 41.3%
FY2021-FY2025
Trend
+180.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from 1.3% in FY2018 to 1088.4% in FY2016.
Based on SEC 10-K filings.
41.3% in FY2025 with a 5-year CAGR of +27.2%.
Improved from 19.9% to 41.3% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +23.9pp
- 5-Year Change
- +27.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 180.8% year-over-year.
- Peak fcf margin was recorded in FY2016.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 41.3% | +180.8% |
| FY2024 | 14.7% | -26.1% |
| FY2023 | 19.9% | +14.6% |
| FY2022 | 17.3% | +112.2% |
| FY2021 | 8.2% | -42.0% |
| FY2020 | 14.1% | +72.5% |
| FY2019 | 8.2% | +514.3% |
| FY2018 | 1.3% | -99.8% |
| FY2017 | 637.1% | -41.5% |
| FY2016 | 1088.4% | +1242.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026